Market revenue in 2023 | USD 2,282.6 million |
Market revenue in 2030 | USD 3,934.7 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 50.87% in 2023. Horizon Databook has segmented the Asia Pacific interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is estimated to witness the fastest growth rate during the forecast period. The high geriatric population, growing risk of heart diseases, and unmet clinical needs are primary factors driving the region’s growth. Furthermore, improving healthcare infrastructure, increasing patient awareness, and rising healthcare expenditure levels in the region are expected to assist manufacturers in capitalizing on these available opportunities.
In January 2021, the Chinese government introduced a centralized procurement process for high-value medical consumables, resulting in a substantial decrease in the expenses associated with Drug-eluting Stents (DES). This move led to increased affordability and accessibility of interventional cardiology procedures using these stents, thereby driving market demand and growth in China.
Moreover, technological advancements in the region are another factor contributing to market growth. Companies in the Asia Pacific region, particularly in countries such as Japan, South Korea, China, and India, have been developing innovative interventional cardiology devices. These include advanced stents, catheters, balloons, and imaging technologies used in procedures such as angioplasty & stent placement.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific interventional cardiology devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account